Skip to content
Close up of genetic testing in lab

Why are some diseases linked to genetics?

28.NOV.2023

Written by Anna Sanniti

Reviewed by Wendi Gill, CGC

We previously discussed how a person with a genetic variant that is linked to a disease, may have a higher chance of developing that disease. This is known as a genetic predisposition or risk. Certain genetic variants may be worth testing. This is because they have been closely linked to some rare diseases.

In this article, we will discuss: 

  • The genes that may be useful to test using our gene panel

  • What is the relationship between these genes and disease?

  • What does it mean if I have one of these genetic variants?

The genes that may be useful to test using our gene panel

11 genes are known to be closely linked to three rare diseases included in our panel. Genetic variants in these genes are all tested together. This type of test is called a gene panel. Only these genes are tested, you will not receive any information relating to other genes. These genes are called BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, EPCAM, LDLR, APOB, PCSK9, and LDLRAP1.

What is the relationship between these genes and disease?

There are certain genetic variants, also called genetic mutations, found on these genes that are related to three rare diseases: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, and Familial Hypercholesterolemia. A variant is a change in the code in a certain location. For example, an ‘A’ may have changed to a ‘G’. It is better to prevent diseases related to these conditions. Genetic testing can be a powerful tool to understand our genetic predisposition. We can use it to work with your healthcare provider and genetic counselor to create the best plan for prevention or treatment.

Hereditary Breast and Ovarian Cancer Syndrome: BRCA1 and BRCA2

  • Women and men who have certain genetic mutations on the BRCA1 and BRCA2 genes have an increased risk of developing breast cancer compared with the general population. 

  • Women also have an increased risk of ovarian cancer. 

  • Men have an increased risk of developing high-grade prostate cancer. 

  • Both men and women with these genes are more likely to get pancreatic cancer.

  • You and your family members are more likely to have a BRCA1 or BRCA2 mutation if your family has a strong history of breast or ovarian cancer at a younger age. [1]

What does it mean if I have one of these genetic variants?

  • If you are a woman, this can increase your risk of developing breast cancer. by 70–80 years of age to 55%–72% if you inherit a BRCA1 variant, and 45%–69% if you inherit a BRCA2 variant. This is compared to about 13% of women in the general population who will develop breast cancer at some time during their lives. [2]

  • If you are a man, by 70–80 years of age you also have a higher risk of developing breast cancer, but to a lesser extent. This is compared to about 0.1% of men in the general population that will develop breast cancer some time during their lives.[3]

  • Mutations in these genes also increase the risk of high-grade prostate cancer.

  • 39%–44% of women who inherit BRCA1 variant and 11%–17% who inherit a BRCA2 variant will develop ovarian cancer by 70–80 years of age. This is compared to 1% of women in the general population who will develop ovarian cancer at some point during their lifetime. [2]

If you have a positive result for these genes, you should speak with your healthcare provider and genetic counselor for guidance.

Lynch Syndrome: MLH1, MSH2, MSH6, PMS2, and EPCAM

  • Lynch syndrome is an inherited cancer syndrome that increases the risk of many cancer types, including colorectal, brain, gallbladder, ovarian, and pancreatic cancer. 

  • Women may also have an increased risk of developing endometrial and ovarian cancer. You may have seen this called hereditary non-polyposis colorectal cancer (HNPCC). 

  • The genes MLH1, MSH2, MSH6, PMS2, and EPCAM are involved in fixing mistakes that may happen during the process of copying our DNA, helping to prevent certain types of cancers. Changes in these genes stop this process from working properly. 

  • Individuals with genetic variants in these genes have an increased risk of developing cancer.

What does it mean if I have one of these genetic variants? 

  • If you have a positive result, then you have up to an 80% lifetime risk of colorectal cancer.

  • If you are a woman, up to a 60% lifetime risk of endometrial cancer. 

  • There is an increase in risk for other types of cancers compared to people without these mutations. [5]

  • The lifetime risk and average age of onset vary based on the specific gene an individual is identified to have a variant. 

If you have a positive result, you should speak with your healthcare provider and genetic counselor for guidance.

Familial Hypercholesterolemia: LDLR, APOB, PCSK9, and LDLRAP1

  • LDL cholesterol is thought of as “bad” cholesterol because it contributes to the creation and build-up of plaques. 

  • Build-up can cause the vessels to narrow and make them less flexible. This can increase the risk of developing cardiovascular diseases at a younger age.

  • The genes LDLR, APOB, PCSK9, and LDLRAP1 regulate the cholesterol levels in your body. 

  • If a mutation on one of these genes is found, and Familial Hypercholesterolemia is diagnosed, cholesterol levels can be regulated using medication.

What does it mean if I have one of these genetic variants?

  • If you have a positive result for these genes, you should speak with your healthcare provider for guidance on medication. 

  • If left untreated, men will have a 50% risk of developing cardiovascular disease by the age of 50.

  • Women will have a 30% risk of developing cardiovascular disease by the age of 60. [7]

  • In very rare cases, a person can have two mutations in both copies of the same gene, resulting in homozygous FH.

People with homozygous FH have extremely high levels of cholesterol and can have heart attacks in childhood.[6] If you have a homozygous FH result, speak with your doctor immediately.

Let’s recap

  • Certain genetic variants have been closely linked to some rare diseases and may be worth testing using a gene panel. 

  • Genetic mutations in genes called BRCA1 and BRCA2 can increase your risk of breast and ovarian cancers as well as high-grade prostate and pancreatic cancer, compared to the risk in the general population.

  • Genetic mutations in genes called MLH1, MSH2, MSH6, PMS2, and EPCAM can increase your risk of colorectal, endometrial, and other types of cancers, compared to the risk in the general population.

  • Genetic mutations in genes called LDLR, APOB, PCSK9, and LDLRAP1 can increase LDL cholesterol and the risk of coronary heart disease, stroke, and atherosclerosis, compared to the risk in the general population.

  • If you have any positive results, you should consult your healthcare provider and genetic counselor for guidance.

Knowledge Hub

References

1. CDC. The BRCA1 and BRCA2 genes. Online: cdc.gov 2. National Cancer Institute. BRCA gene mutations. Online: cancer.gov 3. BMC Cancer. Male BRCA mutation carriers: clinical characteristics and cancer spectrum. Online: bmccancer.biomedcentral.com 4. CDC. Lynch Syndrome. Online: cdc.gov 5. National Library of Medicine. Lynch Syndrome. Online: nih.gov 6. CDC. Familial hypercholesterolemia. Online: cdc.gov 7. NORD. Familial hypercholesterolemia. Online: rarediseases.org